Skip to main content
NewslettersWatchlist

Baxter International Inc(BAX-N)
NYSE

Today's Change
Real-Time Last Update Last Sale Cboe BZX Real-Time
Day Low33.78
Day High35.46
Open:35.46
Price movement based on the high, low and last over the given period.
Previous Close
52-Week High/Low
Volume
Average Volume
Price/Earnings (TTM)
Forward Annual Dividend & Yield
Market Capitalization, $M
5-Day Change
Realtime quote and/or trade prices are not sourced from all markets.
Select a category then submit the form to load news
Barchart
Stocks Settle Higher on Optimism Over President-Elect Trump’s Policies
Barchart
Stocks Mostly Higher on US Economic Optimism
Barchart
Stocks Edge Higher on Optimism Over President-elect Trump’s Agenda
Baystreet
Canada Jobs on Agenda for Next Week
Barchart
Stocks Settle Higher as US Banks Post Solid Earnings Results
Barchart
Stocks Recover Early Losses as US Soft-Landing Prospects Improve
Barchart
Stocks Hang Onto Healthy September Gains as Powell Speaks on Rates
Barchart
Stocks Fall Back as Hawkish Fed Governor Pushes Bond Yields Higher
GlobeNewswire
Spectral Medical Provides August Tigris Trial Update
Barchart
Stocks Settle Higher on Favorable PPI Report
Barchart
Stocks Rally on a Muted US July PPI Report
Barchart
Stocks Climb After US July PPI Rises Less Than Expected
Barchart
Stocks Stabilize and Recover Some of Monday’s Slump
Barchart
Stocks Climb as Dip Buyers Emerge After Monday’s Plunge
Barchart
Stocks Settle Higher on Trump Speculation
Barchart
S&P 500 Posts Record High on Trump Speculation
Barchart
Stocks Higher on Trump Speculation
Barchart
S&P 500 and Nasdaq 100 Post Record Highs on Rate Cut Expectations
Barchart
Stocks Settle Higher on Solid Earnings and Fed Rate Cut Optimism
Barchart
Stocks Climb on Strength in Chips Stocks and Fed Rate Cut Optimism
Barchart
Strength in Chips Stocks Leads the Overall Market Higher
Barchart
Stocks Higher on Economic Optimism

Profile

Baxter International Inc. is a global medical technology company. The company consists of renal and hospital products, providing items such as kidney-dialysis equipment, infusion pumps, and intravenous (IV) solutions. Baxter has been reporting through six revenue segments. Renal Care, Medication Delivery, Pharmaceuticals, Clinical Nutrition, Advanced Surgery, Acute Therapies and Other. Baxter's Renal segment primarily consists of Peritoneal Dialysis (PD) and Hemodialysis (HD) therapies. The portfolio addresses the needs of patients with kidney failure or kidney disease, and their healthcare providers, with a comprehensive range of therapeutic options across home, in-center, and hospital settings for better individualized care.

All market data (will open in new tab) is provided by Barchart Solutions. Copyright © 2024.

Information is provided 'as is' and solely for informational purposes, not for trading purposes or advice. For exchange delays and terms of use, please read disclaimer (will open in new tab).

Copyright © 2024 Morningstar. All Rights Reserved. The information contained herein: (1) is proprietary to Morningstar and/or its content providers; (2) may not be copied or distributed; and (3) is not warranted to be accurate, complete or timely. Neither Morningstar nor its content providers are responsible for any damages or losses arising from any use of this information. Past performance is no guarantee of future results.